PTPA and Alzheimer disease: Moreover, the naturally abundant SET protein, a potent PP2A inhibitor, is found to be elevated in AD brains [99], possibly illustrating reduced PP2A activity allowing for the hyperphosphorylation of cellular substrates to occur unabated and the potentiation of neurodegeneration.